CSPC Pharmaceutical Group (HKG:1093) reported a profit attributable to shareholders of 3.78 billion yuan for the nine months ended Sept. 30, down 15.9% from 4.49 billion yuan a year ago.
Earnings per share were 0.3203 yuan, compared with 0.3783 yuan a year earlier, according to a Friday filing with the Hong Kong Exchange.
Revenue for the period was 22.7 billion yuan, a 4.9% decrease from 23.9 billion yuan in the year-ago period.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。